Investors have been hitting the sell button in a panic in 2025. The post How on earth have CSL shares fallen by 28%? appeared ...

The cell therapy field has long held a transformative ambition: to create "off-the-shelf" treatments that can reach not just ...

Early this year, CircNova, a Michigan startup, raised a $3.3 million seed round for its innovative technology, which utilizes AI to target Cellular RNA. The funding round was led by Houston, ...

In the past week or so, a gold and silver miner, a struggling offshore driller, and a biotech saw some huge insider buying.

The other is a top REIT that cranks out a dividend far more often than the usual U.S. business. It isn't all that difficult ...

Join us as we dissect Summit Therapeutics' potential in the biotech sector. Can their promising drug Ansuvimab overcome the odds, or is this stock a risky bet?

Alector Inc. cuts its workforce by nearly 50% following the failure of its dementia drug trial, signalling challenges in the ...

Ocular Therapeutix (OCUL) shares have shown some movement this month, prompting investors to explore what might be influencing the stock. With recent trading action, there is curiosity about the ...